Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-15 Sale |
2025-05-19 5:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
52 | $424.69 | $22,084 | 23,281 (Direct) |
View |
| 2025-05-01 Sale |
2025-05-05 5:00 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,001 | $0 | $0 | 4,830 (Direct) |
View |
| 2025-05-01 Sale |
2025-05-05 4:52 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,001 | $0 | $0 | 9,429 (Indirect Direct) |
View |
| 2025-05-02 Sale |
2025-05-05 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
400 | $505.86 | $202,344 | 4,831 (Direct) |
View |
| 2025-03-13 Sale |
2025-03-17 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $510 | $1,647,810 | 23,281 (Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,298 | $500 | $1,649,000 | 51,671 (Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,242 | $499.99 | $1,620,968 | 51,239 (Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $500 | $1,615,500 | 26,512 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,058 | $485.49 | $1,970,118 | 54,481 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $490 | $1,583,190 | 29,743 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
530 | $475.34 | $251,930 | 58,539 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
2,650 | $475.34 | $1,259,651 | 19,352 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
1,272 | $480 | $610,560 | 32,974 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-26 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
354 | $480.95 | $170,256 | 64,031 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-26 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,767 | $480.95 | $849,839 | 24,484 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-26 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
884 | $480.95 | $425,160 | 9,086 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-26 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
848 | $480.95 | $407,846 | 40,200 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
1,111 | $480 | $533,280 | 45,019 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
244 | $455.06 | $111,035 | 67,695 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-13 Option Award |
2025-05-15 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
37,622 | $0 | 100,751 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 5:00 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,797 | $0 | 4,830 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:59 pm |
N/A 2035-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Thornberry Nancy Director |
1,597 | $0 | 3,234 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:57 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Schneider Jennifer Director |
796 | $0 | 1,718 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:55 pm |
N/A 2035-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
2,398 | $0 | 2,398 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,797 | $0 | 9,429 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:20 pm |
N/A 2035-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Lagarde Michel Director |
2,398 | $0 | 2,398 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:19 pm |
N/A 2035-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director |
1,597 | $0 | 8,071 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
796 | $0 | 7,115 (Direct) |
View |
| 2025-05-01 Option Award |
2025-05-05 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
796 | $0 | 4,831 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
72 | $497.51 | 1,475 (Direct) |
View |
| 2025-04-15 Option Award |
2025-04-17 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
95 | $497.51 | 15,240 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
4,962 | $479.61 | 54,969 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,962 | $479.61 | 58,539 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,703 | $479.61 | 69,372 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
14,079 | $479.61 | 105,915 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:41 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
4,962 | $479.61 | 32,669 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:36 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
2,482 | $479.61 | 19,352 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:31 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,071 | $479.61 | 63,075 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,241 | $479.61 | 7,845 (Direct) |
View |
| 2025-02-26 Tax Withholding |
2025-02-28 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
5,954 | $479.61 | 32,974 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,310 | $483.28 | 59,931 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,310 | $483.28 | 64,031 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,470 | $483.28 | 73,075 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,386 | $483.28 | 119,994 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,310 | $483.28 | 37,631 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,656 | $483.28 | 24,484 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,716 | $483.28 | 70,146 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
828 | $483.28 | 9,086 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,971 | $483.28 | 40,200 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,293 | $463.46 | 63,241 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:36 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,293 | $463.46 | 67,695 (Direct) |
View |